John S. Montalbano - Nov 6, 2023 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Director
Signature: Tryn Stimart, attorney-in-fact
Stock symbol: ABCL
Transactions as of: Nov 6, 2023
Transactions value $: $137,400
Form type: 4
Date filed: 11/8/2023, 03:29 PM
Previous filing: Dec 5, 2022
Next filing: Jun 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABCL	Common Shares	Purchase	$92.8K	+20K	+35.71%	$4.64	76K	Nov 6, 2023	Direct
transaction	ABCL	Common Shares	Purchase	$44.6K	+10K	+13.16%	$4.46	86K	Nov 8, 2023	Direct	F1
holding	ABCL	Common Shares						5K	Nov 6, 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $4.45 to $4.46. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $4.45 to $4.46. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.